The equivalence of different types of electric pulses for electrochemotherapy with cisplatin − an in vitro study

1. Campana LG, Miklavčič D, Bertino G, Marconato R, Valpione S, Imarisio I, et al. Electrochemotherapy of superficial tumors – current status: basic principles, operating procedures, shared indications, and emerging applications. Sem Oncol 2019; 46: 173–91. doi: 10.1053/j.seminoncol.2019.04.002 CampanaLG MiklavčičD BertinoG MarconatoR ValpioneS ImarisioI Electrochemotherapy of superficial tumors – current status: basic principles, operating procedures, shared indications, and emerging applications Sem Oncol 2019 46 173 91 10.1053/j.seminoncol.2019.04.002 Open DOISearch in Google Scholar

2. Campana LG, Edhemović I, Soden D, Perrone AM, Scarpa M, Campanacci L, et al. Electrochemotherapy – emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol 2019; 45: 92–102. doi: 10.1016/j.ejso.2018.11.023 CampanaLG EdhemovićI SodenD PerroneAM ScarpaM CampanacciL Electrochemotherapy – emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration Eur J Surg Oncol 2019 45 92 102 10.1016/j.ejso.2018.11.023 Open DOISearch in Google Scholar

3. Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, et al. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng Online 2010; 9: 1–12. doi: 10.1186/1475-925X-9-10 MiklavcicD SnojM ZupanicA KosB CemazarM KropivnikM Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy Biomed Eng Online 2010 9 1 12 10.1186/1475-925X-9-10 Open DOISearch in Google Scholar

4. Cindrič H, Miklavčič D, Cornelis FH, Kos B. Optimization of transpedicular electrode insertion for electroporation-based treatments of vertebral tumors. Cancers 2022; 14: 5412. doi: 10.3390/cancers14215412 CindričH MiklavčičD CornelisFH KosB Optimization of transpedicular electrode insertion for electroporation-based treatments of vertebral tumors Cancers 2022 14 5412 10.3390/cancers14215412 Open DOISearch in Google Scholar

5. Edhemovic I, Brecelj E, Gasljevic G, Marolt Music M, Gorjup V, Mali B, et al. Intraoperative electrochemotherapy of colorectal liver metastases. J Surg Oncol 2014; 110: 320–7. doi: 10.1002/jso.23625 EdhemovicI BreceljE GasljevicG Marolt MusicM GorjupV MaliB Intraoperative electrochemotherapy of colorectal liver metastases J Surg Oncol 2014 110 320 7 10.1002/jso.23625 Open DOISearch in Google Scholar

6. Bianchi G, Campanacci L, Ronchetti M, Donati D. Electrochemotherapy in the treatment of bone metastases: a phase II trial. World J Surg 2016; 40: 3088–94. doi: 10.1007/s00268-016-3627-6 BianchiG CampanacciL RonchettiM DonatiD Electrochemotherapy in the treatment of bone metastases: a phase II trial World J Surg 2016 40 3088 94 10.1007/s00268-016-3627-6 Open DOISearch in Google Scholar

7. Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, et al. Electrochemotherapy in locally advanced pancreatic cancer: preliminary results. Int J Surg 2015; 18: 230–6. doi: 10.1016/j.ijsu.2015.04.055. GranataV FuscoR PiccirilloM PalaiaR PetrilloA LastoriaS Electrochemotherapy in locally advanced pancreatic cancer: preliminary results Int J Surg 2015 18 230 6 10.1016/j.ijsu.2015.04.055 Open DOISearch in Google Scholar

8. Simioni A, Valpione S, Granziera E, Rossi CR, Cavallin F, Spina R, et al. Ablation of soft tissue tumours by long needle variable electrode-geometry electrochemotherapy: final report from a single-arm, single-centre phase-2 study. Sci Rep 2020; 10: 2291. doi: 10.1038/s41598-020-59230-w SimioniA ValpioneS GranzieraE RossiCR CavallinF SpinaR Ablation of soft tissue tumours by long needle variable electrode-geometry electrochemotherapy: final report from a single-arm, single-centre phase-2 study Sci Rep 2020 10 2291 10.1038/s41598-020-59230-w Open DOISearch in Google Scholar

9. Tarantino L, Busto G, Nasto A, Nasto RA, Tarantino P, Fristachi R, et al. Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a feasibility study. Eur J Surg Oncol 2018; 44: 1603–9. doi: 10.1016/j.ejso.2018.06.025 TarantinoL BustoG NastoA NastoRA TarantinoP FristachiR Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: a feasibility study Eur J Surg Oncol 2018 44 1603 9 10.1016/j.ejso.2018.06.025 Open DOISearch in Google Scholar

10. Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874–82. doi: 10.1080/0284186X.2018.1454602 GehlJ SersaG MatthiessenLW MuirT SodenD OcchiniA Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases Acta Oncol 2018 57 874 82 10.1080/0284186X.2018.1454602 Open DOISearch in Google Scholar

11. Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 2006; 4: 14–25. doi: 10.1016/j.ejcsup.2006.08.003 MirLM GehlJ SersaG CollinsCG GarbayJR BillardV Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes Eur J Cancer Suppl 2006 4 14 25 10.1016/j.ejcsup.2006.08.003 Open DOISearch in Google Scholar

12. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M. Electrochemotherapy in treatment of tumours. Eur J Surg Oncol EJSO 2008; 34: 232–40. doi: 10.1016/j.ejso.2007.05.016 SersaG MiklavcicD CemazarM RudolfZ PuciharG SnojM Electrochemotherapy in treatment of tumours Eur J Surg Oncol EJSO 2008 34 232 40 10.1016/j.ejso.2007.05.016 Open DOISearch in Google Scholar

13. Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res 1995; 55: 3450–5. PMID: 7614485 SersaG CemazarM MiklavcicD Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice Cancer Res 1995 55 3450 5 7614485 Search in Google Scholar

14. Orlowski S, Belehradek Jr J, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture: increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988; 37: 4727–33. doi: 10.1016/0006-2952(88)90344-9 OrlowskiS BelehradekJJr PaolettiC MirLM Transient electropermeabilization of cells in culture: increase of the cytotoxicity of anticancer drugs Biochem Pharmacol 1988 37 4727 33 10.1016/0006-2952(88)90344-9 Open DOISearch in Google Scholar

15. Mir LM. Bases and rationale of the electrochemotherapy. Eur J Cancer Suppl 2006; 4: 38–44. doi: 10.1016/j.ejcsup.2006.08.005 MirLM Bases and rationale of the electrochemotherapy Eur J Cancer Suppl 2006 4 38 44 10.1016/j.ejcsup.2006.08.005 Open DOISearch in Google Scholar

16. Jarm T, Cemazar M, Miklavcic D, Sersa G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010; 10: 729–46. doi: 10.1586/era.10.43 JarmT CemazarM MiklavcicD SersaG Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases Expert Rev Anticancer Ther 2010 10 729 46 10.1586/era.10.43 Open DOISearch in Google Scholar

17. Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 2008; 98: 388–98. doi: 10.1038/sj.bjc.6604168 SersaG JarmT KotnikT CoerA PodkrajsekM SentjurcM Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma Br J Cancer 2008 98 388 98 10.1038/sj.bjc.6604168 Open DOISearch in Google Scholar

18. Markelc B, Sersa G, Cemazar M. Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PloS One 2013; 8: e59557. doi: 10.1371/journal.pone.0059557 MarkelcB SersaG CemazarM Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels PloS One 2013 8 e59557 10.1371/journal.pone.0059557 Open DOISearch in Google Scholar

19. Serša G, Miklavčič D, Čemažar M, Belehradek Jr J, Jarm T, Mir LM. Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompotent and immunodeficient mice. Bioelectrochem Bioenerg 1997; 43: 279–83. doi: 10.1016/S0302-4598(96)05194-X SeršaG MiklavčičD ČemažarM BelehradekJJr JarmT MirLM Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunocompotent and immunodeficient mice Bioelectrochem Bioenerg 1997 43 279 83 10.1016/S0302-4598(96)05194-X Open DOISearch in Google Scholar

20. Calvet CY, Mir LM. The promising alliance of anti-cancer electrochemotherapy with immunotherapy. Cancer Metastasis Rev 2016; 35: 165–77. doi: 10.1007/s10555-016-9615-3 CalvetCY MirLM The promising alliance of anti-cancer electrochemotherapy with immunotherapy Cancer Metastasis Rev 2016 35 165 77 10.1007/s10555-016-9615-3 Open DOISearch in Google Scholar

21. Miklavčič D, Mali B, Kos B, Heller R, Serša G. Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online 2014; 13: 1–20. doi: 10.1186/1475-925X-13-29 MiklavčičD MaliB KosB HellerR SeršaG Electrochemotherapy: from the drawing board into medical practice Biomed Eng Online 2014 13 1 20 10.1186/1475-925X-13-29 Open DOISearch in Google Scholar

22. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3–13. doi: 10.1016/j.ejcsup.2006.08.002 MartyM SersaG GarbayJR GehlJ CollinsCG SnojM Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study Eur J Cancer Suppl 2006 4 3 13 10.1016/j.ejcsup.2006.08.002 Open DOISearch in Google Scholar

23. Sano MB, Fan RE, Cheng K, Saenz Y, Sonn GA, Hwang GL, et al. Reduction of muscle contractions during irreversible electroporation therapy using high-frequency bursts of alternating polarity pulses: a laboratory investigation in an ex vivo swine model. J Vasc Interv Radiol 2018; 29: 893–8.e4. doi: 10.1016/j.jvir.2017.12.019 SanoMB FanRE ChengK SaenzY SonnGA HwangGL Reduction of muscle contractions during irreversible electroporation therapy using high-frequency bursts of alternating polarity pulses: a laboratory investigation in an ex vivo swine model J Vasc Interv Radiol 2018 29 893 8.e4 10.1016/j.jvir.2017.12.019 Open DOISearch in Google Scholar

24. Fusco R, Di Bernardo E, D’Alessio V, Salati S, Cadossi M. Reduction of muscle contraction and pain in electroporation-based treatments: an overview. World J Clin Oncol 2021; 12: 367. doi: 10.5306/wjco.v12.i5.367 FuscoR Di BernardoE D’AlessioV SalatiS CadossiM Reduction of muscle contraction and pain in electroporation-based treatments: an overview World J Clin Oncol 2021 12 367 10.5306/wjco.v12.i5.367 Open DOISearch in Google Scholar

25. Miklavcic D, Corovic S, Pucihar G, Pavselj N. Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. Eur J Cancer Suppl 2006; 4: 45–51. doi: 10.1016/j.ejcsup.2006.08.006 MiklavcicD CorovicS PuciharG PavseljN Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy Eur J Cancer Suppl 2006 4 45 51 10.1016/j.ejcsup.2006.08.006 Open DOISearch in Google Scholar

26. Martin RC, Schwartz E, Adams J, Farah I, Derhake BM. Intra-operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors. Anesthesiol Pain Med 2015; 5: e22786. doi: 10.5812/aapm.22786 MartinRC SchwartzE AdamsJ FarahI DerhakeBM Intra-operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors Anesthesiol Pain Med 2015 5 e22786 10.5812/aapm.22786 Open DOISearch in Google Scholar

27. Deodhar A, Dickfeld T, Single GW, Hamilton Jr WC, Thornton RH, Sofocleous CT, et al. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. Am J Roentgenol 2011; 196: W330–5. doi: 10.2214/AJR.10.4490 DeodharA DickfeldT SingleGW HamiltonWCJr ThorntonRH SofocleousCT Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization Am J Roentgenol 2011 196 W330 5 10.2214/AJR.10.4490 Open DOISearch in Google Scholar

28. Mali B, Jarm T, Corovic S, Paulin-Kosir MS, Cemazar M, Sersa G, et al. The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 2008; 46: 745–57. doi: 10.1007/s11517-008-0346-7 MaliB JarmT CorovicS Paulin-KosirMS CemazarM SersaG The effect of electroporation pulses on functioning of the heart Med Biol Eng Comput 2008 46 745 57 10.1007/s11517-008-0346-7 Open DOISearch in Google Scholar

29. Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg 2010; 110: 1305–9. doi: 10.1213/ane.0b013e3181d27b30 BallC ThomsonKR KavnoudiasH Irreversible electroporation: a new challenge in “out of operating theater” anesthesia Anesth Analg 2010 110 1305 9 10.1213/ane.0b013e3181d27b30 Open DOISearch in Google Scholar

30. Cannon R, Ellis S, Hayes D, Narayanan G, Martin RC. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 2013; 107: 544–9. doi: 10.1002/jso.23280 CannonR EllisS HayesD NarayananG MartinRC Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures J Surg Oncol 2013 107 544 9 10.1002/jso.23280 Open DOISearch in Google Scholar

31. Spallek H, Bischoff P, Zhou W, de Terlizzi F, Jakob F, Kovàcs A. Percutaneous electrochemotherapy in primary and secondary liver malignancies–local tumor control and impact on overall survival. Radiol Oncol 2022; 56: 102–10. doi: 10.2478/raon-2022-0003 SpallekH BischoffP ZhouW de TerlizziF JakobF KovàcsA Percutaneous electrochemotherapy in primary and secondary liver malignancies–local tumor control and impact on overall survival Radiol Oncol 2022 56 102 10 10.2478/raon-2022-0003 Open DOISearch in Google Scholar

32. Cvetkoska A, Maček-Lebar A, Trdina P, Miklavčič D, Reberšek M. Muscle contractions and pain sensation accompanying high-frequency electroporation pulses. Sci Rep 2022; 12: 1–15. doi: 10.1038/s41598-022-12112-9 CvetkoskaA Maček-LebarA TrdinaP MiklavčičD ReberšekM Muscle contractions and pain sensation accompanying high-frequency electroporation pulses Sci Rep 2022 12 1 15 10.1038/s41598-022-12112-9 Open DOISearch in Google Scholar

33. Arena CB, Sano MB, Rossmeisl JH, Caldwell JL, Garcia PA, Rylander MN, et al. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction. Biomed Eng Online 2011; 10: 1–21. doi: 10.1186/1475-925X-10-102 ArenaCB SanoMB RossmeislJH CaldwellJL GarciaPA RylanderMN High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction Biomed Eng Online 2011 10 1 21 10.1186/1475-925X-10-102 Open DOISearch in Google Scholar

34. Dong S, Wang H, Zhao Y, Sun Y, Yao C. First human trial of high-frequency irreversible electroporation therapy for prostate cancer. Technol Cancer Res Treat 2018; 17: 1533033818789692. doi: 10.1177/1533033818789692 DongS WangH ZhaoY SunY YaoC First human trial of high-frequency irreversible electroporation therapy for prostate cancer Technol Cancer Res Treat 2018 17 1533033818789692 10.1177/1533033818789692 Open DOISearch in Google Scholar

35. van Es R, Konings MK, Du Pré BC, Neven K, van Wessel H, van Driel VJ, et al. High-frequency irreversible electroporation for cardiac ablation using an asymmetrical waveform. Biomed Eng OnLine 2019; 18: 1–13. doi: 10.1186/s12938-019-0693-7 van EsR KoningsMK Du PréBC NevenK van WesselH van DrielVJ High-frequency irreversible electroporation for cardiac ablation using an asymmetrical waveform Biomed Eng OnLine 2019 18 1 13 10.1186/s12938-019-0693-7 Open DOISearch in Google Scholar

36. Ye X, Liu S, Yin H, He Q, Xue Z, Lu C, et al. Study on optimal parameter and target for pulsed-field ablation of atrial fibrillation. Front Cardiovasc Med 2021; 8: 690092. doi: 10.3389/fcvm.2021.690092 YeX LiuS YinH HeQ XueZ LuC Study on optimal parameter and target for pulsed-field ablation of atrial fibrillation Front Cardiovasc Med 2021 8 690092 10.3389/fcvm.2021.690092 Open DOISearch in Google Scholar

37. Hartl S, Reinsch N, Füting A, Neven K. Pearls and pitfalls of pulsed field ablation. Korean Circ J 2022; 53: 273–93. doi: 10.4070/kcj.2023.0023 HartlS ReinschN FütingA NevenK Pearls and pitfalls of pulsed field ablation Korean Circ J 2022 53 273 93 10.4070/kcj.2023.0023 Open DOISearch in Google Scholar

38. Scuderi M, Rebersek M, Miklavcic D, Dermol-Cerne J. The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro. Radiol Oncol 2019; 53: 194–205. doi: 10.2478/raon-2019-0025 ScuderiM RebersekM MiklavcicD Dermol-CerneJ The use of high-frequency short bipolar pulses in cisplatin electrochemotherapy in vitro Radiol Oncol 2019 53 194 205 10.2478/raon-2019-0025 Open DOISearch in Google Scholar

39. Sweeney DC, Reberšek M, Dermol J, Rems L, Miklavčič D, Davalos RV. Quantification of cell membrane permeability induced by monopolar and high-frequency bipolar bursts of electrical pulses. Biochim Biophys Acta BBA-Biomembr 2016; 1858: 2689–98. doi: 10.1016/j.bbamem.2016.06.024 SweeneyDC ReberšekM DermolJ RemsL MiklavčičD DavalosRV Quantification of cell membrane permeability induced by monopolar and high-frequency bipolar bursts of electrical pulses Biochim Biophys Acta BBA-Biomembr 2016 1858 2689 98 10.1016/j.bbamem.2016.06.024 Open DOISearch in Google Scholar

40. Lyons P, Polini D, Russell-Ryan K, Clover AJP. High-frequency electroporation and chemotherapy for the treatment of cutaneous malignancies: evaluation of early clinical response. Cancers 2023; 15: 3212. doi: 10.3390/cancers15123212 LyonsP PoliniD Russell-RyanK CloverAJP High-frequency electroporation and chemotherapy for the treatment of cutaneous malignancies: evaluation of early clinical response Cancers 2023 15 3212 10.3390/cancers15123212 Open DOISearch in Google Scholar

41. Pfefferle V, Häfner HM, Saur A, Kofler K, Kofler L. Electrochemotherapy in analgosedation for patients with reduced ability to receive general anesthesia. JDDG J Dtsch Dermatol Ges 2022; 20: 1384–6. doi: 10.1111/ddg.14855. PfefferleV HäfnerHM SaurA KoflerK KoflerL Electrochemotherapy in analgosedation for patients with reduced ability to receive general anesthesia JDDG J Dtsch Dermatol Ges 2022 20 1384 6 10.1111/ddg.14855 Open DOISearch in Google Scholar

42. Pfefferle V, Leiter U, Grünke T, Kofler K, Häfner HM, Kofler L. Electrochemotherapy under analgosedation – case report of a patient with Kaposi’s sarcoma. J Eur Acad Dermatol Venereol 2023; 37: e209–11. doi: 10.1111/jdv.18518 PfefferleV LeiterU GrünkeT KoflerK HäfnerHM KoflerL Electrochemotherapy under analgosedation – case report of a patient with Kaposi’s sarcoma J Eur Acad Dermatol Venereol 2023 37 e209 11 10.1111/jdv.18518 Open DOISearch in Google Scholar

43. Mir LM, Orlowski S, Belehradek Jr J, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer Clin Oncol 1991; 27: 68–72. doi: 10.1016/0277-5379(91)90064-k MirLM OrlowskiS BelehradekJJr PaolettiC Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses Eur J Cancer Clin Oncol 1991 27 68 72 10.1016/0277-5379(91)90064-k Open DOISearch in Google Scholar

44. Trotovšek B, Djokić M, Čemažar M, Serša G. New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies. World J Gastroenterol 2021; 27: 8216. doi: 10.3748/wjg.v27.i48.8216 TrotovšekB DjokićM ČemažarM SeršaG New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies World J Gastroenterol 2021 27 8216 10.3748/wjg.v27.i48.8216 Open DOISearch in Google Scholar

45. Heller R, Gilbert R, Jaroszeski MJ. Electrochemotherapy of murine melanoma using intratumor drug administration. Methods Mol Med 2000; 37: 253–7. doi: 10.1385/1-59259-080-2:253. HellerR GilbertR JaroszeskiMJ Electrochemotherapy of murine melanoma using intratumor drug administration Methods Mol Med 2000 37 253 7 10.1385/1-59259-080-2:253 Open DOISearch in Google Scholar

46. Sedlar A, Jesenko T, Markelc B, Prosen L. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity. Radiol Oncol 2012; 46: 302–11. doi: 10.2478/v10019-012-0044-9 SedlarA JesenkoT MarkelcB ProsenL Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity Radiol Oncol 2012 46 302 11 10.2478/v10019-012-0044-9 Open DOISearch in Google Scholar

47. Ursic K, Kos S, Kamensek U, Cemažar M, Miceska S, Markelc B, et al. Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status. J Controlled Release 2021; 332: 623–35. doi: 10.1016/j.jconrel.2021.03.009 UrsicK KosS KamensekU CemažarM MiceskaS MarkelcB Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status J Controlled Release 2021 332 623 35 10.1016/j.jconrel.2021.03.009 Open DOISearch in Google Scholar

48. Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother 2015; 64: 1315–27. doi: 10.1007/s00262-015-1724-2 SersaG TeissieJ CemazarM SignoriE KamensekU MarshallG Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer Cancer Immunol Immunother 2015 64 1315 27 10.1007/s00262-015-1724-2 Open DOISearch in Google Scholar

49. Rosazza C, Haberl Meglic S, Zumbusch A, Rols MP, Miklavcic D. Gene electrotransfer: a mechanistic perspective. Curr Gene Ther 2016; 16: 98–129. doi: 10.2174/1566523216666160331130040 RosazzaC Haberl MeglicS ZumbuschA RolsMP MiklavcicD Gene electrotransfer: a mechanistic perspective Curr Gene Ther 2016 16 98 129 10.2174/1566523216666160331130040 Open DOISearch in Google Scholar

50. Radzevičiūtė E, Malyško-Ptašinskė V, Kulbacka J, Rembia\lkowska N, Novickij J, Girkontaitė I, et al. Nanosecond electrochemotherapy using bleomycin or doxorubicin: influence of pulse amplitude, duration and burst frequency. Bioelectrochemistry 2022; 148: 108251. doi: 10.1016/j.bioelechem.2022.108251 RadzevičiūtėE Malyško-PtašinskėV KulbackaJ Rembia\lkowskaN NovickijJ GirkontaitėI Nanosecond electrochemotherapy using bleomycin or doxorubicin: influence of pulse amplitude, duration and burst frequency Bioelectrochemistry 2022 148 108251 10.1016/j.bioelechem.2022.108251 Open DOISearch in Google Scholar

51. Novickij V, Balevičiūtė A, Malyško V, Želvys A, Radzevičiūtė E, Kos B, et al. Effects of time delay between unipolar pulses in high frequency nano-electrochemotherapy. IEEE Trans Biomed Eng 2021; 69: 1726–32. doi: 10.1109/TBME.2021.3129176 NovickijV BalevičiūtėA MalyškoV ŽelvysA RadzevičiūtėE KosB Effects of time delay between unipolar pulses in high frequency nano-electrochemotherapy IEEE Trans Biomed Eng 2021 69 1726 32 10.1109/TBME.2021.3129176 Open DOISearch in Google Scholar

52. Vizintin A, Markovic S, Scancar J, Kladnik J, Turel I, Miklavcic D. Nanosecond electric pulses are equally effective in electrochemotherapy with cisplatin as microsecond pulses. Radiol Oncol 2022; 56: 326–35. doi: 10.2478/raon-2022-0028 VizintinA MarkovicS ScancarJ KladnikJ TurelI MiklavcicD Nanosecond electric pulses are equally effective in electrochemotherapy with cisplatin as microsecond pulses Radiol Oncol 2022 56 326 35 10.2478/raon-2022-0028 Open DOISearch in Google Scholar

53. Cemazar M, Sersa G, Frey W, Miklavcic D, Teissié J. Recommendations and requirements for reporting on applications of electric pulse delivery for electroporation of biological samples. Bioelectrochemistry 2018; 122: 69–76. doi: 10.1016/j.bioelechem.2018.03.005 CemazarM SersaG FreyW MiklavcicD TeissiéJ Recommendations and requirements for reporting on applications of electric pulse delivery for electroporation of biological samples Bioelectrochemistry 2018 122 69 76 10.1016/j.bioelechem.2018.03.005 Open DOISearch in Google Scholar

54. Protocol AG. CellTiter 96® AQueous One Solution Cell Proliferation Assay. Promega USA. [Internet]. [cited 2023 Oct 15]. Available at: https://www.promega.com/-/media/files/resources/protocols/technical-bulletins/0/celltiter-96-aqueous-one-solution-cell-proliferation-assay-system-protocol.pdf ProtocolAG CellTiter 96® AQueous One Solution Cell Proliferation Assay Promega USA [Internet]. [cited 2023 Oct 15]. Available at: https://www.promega.com/-/media/files/resources/protocols/technical-bulletins/0/celltiter-96-aqueous-one-solution-cell-proliferation-assay-system-protocol.pdf Search in Google Scholar

55. Franken NA, Rodermond HM, Stap J, Haveman J, Van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006; 1: 2315–19. doi: 10.1038/nprot.2006.339 FrankenNA RodermondHM StapJ HavemanJ Van BreeC Clonogenic assay of cells in vitro Nat Protoc 2006 1 2315 19 10.1038/nprot.2006.339 Open DOISearch in Google Scholar

56. Sweeney DC, Douglas TA, Davalos RV. Characterization of cell membrane permeability in vitro part II: computational model of electroporation-mediated membrane transport. Technol Cancer Res Treat 2018; 17: 1533033818792490. doi: 10.1177/1533033818792490 SweeneyDC DouglasTA DavalosRV Characterization of cell membrane permeability in vitro part II: computational model of electroporation-mediated membrane transport Technol Cancer Res Treat 2018 17 1533033818792490 10.1177/1533033818792490 Open DOISearch in Google Scholar

57. Mahnič-Kalamiza S, Miklavčič D, Vorobiev E. Dual-porosity model of solute diffusion in biological tissue modified by electroporation. Biochim Biophys Acta BBA-Biomembr 2014; 1838: 1950–66. doi: 10.1016/j.bbamem.2014.03.004 Mahnič-KalamizaS MiklavčičD VorobievE Dual-porosity model of solute diffusion in biological tissue modified by electroporation Biochim Biophys Acta BBA-Biomembr 2014 1838 1950 66 10.1016/j.bbamem.2014.03.004 Open DOISearch in Google Scholar

58. Nejad MA, Urbassek HM. Diffusion of cisplatin molecules in silica nano-pores: molecular dynamics study of a targeted drug delivery system. J Mol Graph Model 2019; 86: 228–34. doi: 10.1016/j.jmgm.2018.10.021 NejadMA UrbassekHM Diffusion of cisplatin molecules in silica nano-pores: molecular dynamics study of a targeted drug delivery system J Mol Graph Model 2019 86 228 34 10.1016/j.jmgm.2018.10.021 Open DOISearch in Google Scholar

59. Panczyk T, Jagusiak A, Pastorin G, Ang WH, Narkiewicz-Michalek J. Molecular dynamics study of cisplatin release from carbon nanotubes capped by magnetic nanoparticles. J Phys Chem C 2013; 117: 17327–36. doi: 10.1021/jp405593u PanczykT JagusiakA PastorinG AngWH Narkiewicz-MichalekJ Molecular dynamics study of cisplatin release from carbon nanotubes capped by magnetic nanoparticles J Phys Chem C 2013 117 17327 36 10.1021/jp405593u Open DOISearch in Google Scholar

60. Jakštys B, Ruzgys P, Tamošiūnas M, Šatkauskas S. Different cell viability assays reveal inconsistent results after bleomycin electrotransfer in vitro. J Membr Biol 2015; 248: 857–63. doi: 10.1007/s00232-015-9813-x JakštysB RuzgysP TamošiūnasM ŠatkauskasS Different cell viability assays reveal inconsistent results after bleomycin electrotransfer in vitro J Membr Biol 2015 248 857 63 10.1007/s00232-015-9813-x Open DOISearch in Google Scholar

61. Hucke A, Ciarimboli G. The role of transporters in the toxicity of chemotherapeutic drugs: focus on transporters for organic cations. J Clin Pharmacol 2016; 56: S157–72. doi: 10.1002/jcph.706 HuckeA CiarimboliG The role of transporters in the toxicity of chemotherapeutic drugs: focus on transporters for organic cations J Clin Pharmacol 2016 56 S157 72 10.1002/jcph.706 Open DOISearch in Google Scholar

62. Makovec T. Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy. Radiol Oncol 2019; 53: 148–58. doi: 10.2478/raon-2019-0018 MakovecT Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy Radiol Oncol 2019 53 148 58 10.2478/raon-2019-0018 Open DOISearch in Google Scholar

63. Howell SB, Safaei R, Larson CA, Sailor MJ. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Mol Pharmacol 2010; 77: 887–94. doi: 10.1124/mol.109.063172 HowellSB SafaeiR LarsonCA SailorMJ Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs Mol Pharmacol 2010 77 887 94 10.1124/mol.109.063172 Open DOISearch in Google Scholar

64. Spreckelmeyer S, Orvig C, Casini A. Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin. Molecules 2014; 19: 15584–610. doi: 10.3390/molecules191015584 SpreckelmeyerS OrvigC CasiniA Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin Molecules 2014 19 15584 610 10.3390/molecules191015584 Open DOISearch in Google Scholar

65. Shen DW, Pouliot LM, Hall MD, Gottesman MM. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev 2012; 64: 706–21. doi: 10.1124/pr.111.005637 ShenDW PouliotLM HallMD GottesmanMM Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes Pharmacol Rev 2012 64 706 21 10.1124/pr.111.005637 Open DOISearch in Google Scholar

66. Pucihar G, Krmelj J, Reberšek M, Napotnik TB, Miklavčič D. Equivalent pulse parameters for electroporation. IEEE Trans Biomed Eng 2011; 58: 3279–88. doi: 10.1109/TBME.2011.2167232 PuciharG KrmeljJ ReberšekM NapotnikTB MiklavčičD Equivalent pulse parameters for electroporation IEEE Trans Biomed Eng 2011 58 3279 88 10.1109/TBME.2011.2167232 Open DOISearch in Google Scholar

67. Peng W, Polajžer T, Yao C, Miklavčič D. Dynamics of cell death due to electroporation using different pulse parameters as revealed by different viability assays. Ann Biomed Eng 2023. [Internet]. doi: 10.1007/s10439-023-03309-8. Available at: https://www.researchgate.net/publication/373911137_Dynamics_of_Cell_Death_Due_to_Electroporation_Using_Different_Pulse_Parameters_as_Revealed_by_Different_Viability_Assays PengW PolajžerT YaoC MiklavčičD Dynamics of cell death due to electroporation using different pulse parameters as revealed by different viability assays Ann Biomed Eng 2023 [Internet]. 10.1007/s10439-023-03309-8 Available at: https://www.researchgate.net/publication/373911137_Dynamics_of_Cell_Death_Due_to_Electroporation_Using_Different_Pulse_Parameters_as_Revealed_by_Different_Viability_Assays Open DOISearch in Google Scholar

68. Dermol-Černe J, Vidmar J, Ščančar J, Uršič K, Serša G, Miklavčič D. Connecting the in vitro and in vivo experiments in electrochemotherapy-a feasibility study modeling cisplatin transport in mouse melanoma using the dual-porosity model. J Controlled Release 2018; 286: 33–45. doi: 10.1016/j.jconrel.2018.07.021 Dermol-ČerneJ VidmarJ ŠčančarJ UršičK SeršaG MiklavčičD Connecting the in vitro and in vivo experiments in electrochemotherapy-a feasibility study modeling cisplatin transport in mouse melanoma using the dual-porosity model J Controlled Release 2018 286 33 45 10.1016/j.jconrel.2018.07.021 Open DOISearch in Google Scholar

69. Daley-Yates PT, McBrien DC. Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin. Biochem Pharmacol 1984; 33: 3063–70. doi: 10.1016/0006-2952(84)90610-5 Daley-YatesPT McBrienDC Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin Biochem Pharmacol 1984 33 3063 70 10.1016/0006-2952(84)90610-5 Open DOISearch in Google Scholar

70. Gately DP, Howell SB. Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 1993; 67: 1171–6. doi: 10.1038/bjc.1993.221 GatelyDP HowellSB Cellular accumulation of the anticancer agent cisplatin: a review Br J Cancer 1993 67 1171 6 10.1038/bjc.1993.221 Open DOISearch in Google Scholar

71. Rols MP, Femenia P, Teissie J. Long-lived macropinocytosis takes place in electropermeabilized mammalian cells. Biochem Biophys Res Commun 1995; 208: 26–35. doi: 10.1006/bbrc.1995.1300 RolsMP FemeniaP TeissieJ Long-lived macropinocytosis takes place in electropermeabilized mammalian cells Biochem Biophys Res Commun 1995 208 26 35 10.1006/bbrc.1995.1300 Open DOISearch in Google Scholar

72. Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer 2020; 138: 30–40. doi: 10.1016/j.ejca.2020.06.020 CloverAJP de TerlizziF BertinoG CuratoloP OdiliJ CampanaLG Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019) Eur J Cancer 2020 138 30 40 10.1016/j.ejca.2020.06.020 Open DOISearch in Google Scholar

73. Cornelis FH, Ben Ammar M, Nouri-Neuville M, Matton L, Benderra MA, Gligorov J, et al. Percutaneous image-guided electrochemotherapy of spine metastases: initial experience. Cardiovasc Intervent Radiol 2019; 42: 1806–9. doi: 10.1007/s00270-019-02316-4 CornelisFH Ben AmmarM Nouri-NeuvilleM MattonL BenderraMA GligorovJ Percutaneous image-guided electrochemotherapy of spine metastases: initial experience Cardiovasc Intervent Radiol 2019 42 1806 9 10.1007/s00270-019-02316-4 Open DOISearch in Google Scholar

74. Tarantino L, Busto G, Nasto A, Fristachi R, Cacace L, Talamo M, et al. Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: a feasibility study. World J Gastroenterol 2017; 23: 906. doi: 10.3748/wjg.v23.i5.906 TarantinoL BustoG NastoA FristachiR CacaceL TalamoM Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: a feasibility study World J Gastroenterol 2017 23 906 10.3748/wjg.v23.i5.906 Open DOISearch in Google Scholar

75. Djokic M, Cemazar M, Stabuc M, Petric M, Smid LM, Jansa R, et al. Percutaneous image guided electrochemotherapy of hepatocellular carcinoma: technological advancement. Radiol Oncol 2020; 54: 347–52. doi: 10.2478/raon-2020-0038 DjokicM CemazarM StabucM PetricM SmidLM JansaR Percutaneous image guided electrochemotherapy of hepatocellular carcinoma: technological advancement Radiol Oncol 2020 54 347 52 10.2478/raon-2020-0038 Open DOISearch in Google Scholar

76. Gudvangen E, Kim V, Novickij V, Battista F, Pakhomov AG. Electroporation and cell killing by milli-to nanosecond pulses and avoiding neuromuscular stimulation in cancer ablation. Sci Rep 2022; 12: 1–15. doi: 10.1038/s41598-022-04868-x GudvangenE KimV NovickijV BattistaF PakhomovAG Electroporation and cell killing by milli-to nanosecond pulses and avoiding neuromuscular stimulation in cancer ablation Sci Rep 2022 12 1 15 10.1038/s41598-022-04868-x Open DOISearch in Google Scholar

77. Kim V, Gudvangen E, Kondratiev O, Redondo L, Xiao S, Pakhomov AG. Peculiarities of neurostimulation by intense nanosecond pulsed electric fields: how to avoid firing in peripheral nerve fibers. Int J Mol Sci 2021; 22: 7051. doi: 10.3390/ijms22137051 KimV GudvangenE KondratievO RedondoL XiaoS PakhomovAG Peculiarities of neurostimulation by intense nanosecond pulsed electric fields: how to avoid firing in peripheral nerve fibers Int J Mol Sci 2021 22 7051 10.3390/ijms22137051 Open DOISearch in Google Scholar

78. Jung J, Kim DH, Son J, Lee SK, Son BS. Comparative study between local anesthesia and general anesthesia in the treatment of primary spontaneous pneumothorax. Ann Transl Med 2019; 7: 553. doi: 10.21037/atm.2019.09.89 JungJ KimDH SonJ LeeSK SonBS Comparative study between local anesthesia and general anesthesia in the treatment of primary spontaneous pneumothorax Ann Transl Med 2019 7 553 10.21037/atm.2019.09.89 Open DOISearch in Google Scholar

79. Vižintin A, Marković S, Ščančar J, Miklavčič D. Electroporation with nanosecond pulses and bleomycin or cisplatin results in efficient cell kill and low metal release from electrodes. Bioelectrochemistry 2021; 140: 107798. doi: 10.1016/j.bioelechem.2021.107798 VižintinA MarkovićS ŠčančarJ MiklavčičD Electroporation with nanosecond pulses and bleomycin or cisplatin results in efficient cell kill and low metal release from electrodes Bioelectrochemistry 2021 140 107798 10.1016/j.bioelechem.2021.107798 Open DOISearch in Google Scholar

80. Bendix MB, Houston A, Forde PF, Brint E. Electrochemotherapy and immune interactions; a boost to the system? Eur J Surg Oncol 2022; 48: 1895–900. doi: 10.1016/j.ejso.2022.05.023 BendixMB HoustonA FordePF BrintE Electrochemotherapy and immune interactions; a boost to the system? Eur J Surg Oncol 2022 48 1895 900 10.1016/j.ejso.2022.05.023 Open DOISearch in Google Scholar

81. Groselj A, Bosnjak M, Jesenko T, Cemazar M, Markelc B, Strojan P, et al. Treatment of skin tumors with intratumoral interleukin 12 gene electrotransfer in the head and neck region: a first-in-human clinical trial protocol. Radiol Oncol 2022; 56: 398–408. doi: 10.2478/raon-2022-0021 GroseljA BosnjakM JesenkoT CemazarM MarkelcB StrojanP Treatment of skin tumors with intratumoral interleukin 12 gene electrotransfer in the head and neck region: a first-in-human clinical trial protocol Radiol Oncol 2022 56 398 408 10.2478/raon-2022-0021 Open DOISearch in Google Scholar

82. Napotnik TB, Polajžer T, Miklavčič D. Cell death due to electroporation–a review. Bioelectrochemistry 2021; 141: 107871. doi: 10.1016/j.bioelechem.2021.107871 NapotnikTB PolajžerT MiklavčičD Cell death due to electroporation–a review Bioelectrochemistry 2021 141 107871 10.1016/j.bioelechem.2021.107871 Open DOISearch in Google Scholar

83. Kesar U, Markelc B, Jesenko T, Ursic Valentinuzzi K, Cemazar M, Strojan P, et al. Effects of electrochemotherapy on immunologically important modifications in tumor cells. Vaccines 2023; 11: 925. doi: 10.3390/vaccines11050925 KesarU MarkelcB JesenkoT Ursic ValentinuzziK CemazarM StrojanP Effects of electrochemotherapy on immunologically important modifications in tumor cells Vaccines 2023 11 925 10.3390/vaccines11050925 Open DOISearch in Google Scholar

84. Calvet CY, Famin D, André FM, Mir LM. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. OncoImmunology 2014; 3: e28131. doi: 10.4161/onci.28131 CalvetCY FaminD AndréFM MirLM Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells OncoImmunology 2014 3 e28131 10.4161/onci.28131 Open DOISearch in Google Scholar

85. Gerlini G, Di Gennaro P, Borgognoni L. Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation. Oncoimmunology 2012; 1: 1655–7. doi: 10.4161/onci.21991 GerliniG Di GennaroP BorgognoniL Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation Oncoimmunology 2012 1 1655 7 10.4161/onci.21991 Open DOISearch in Google Scholar

86. Gerlini G, Sestini S, Di Gennaro P, Urso C, Pimpinelli N, Borgognoni L. Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy. Clin Exp Metastasis 2013; 30: 37–45. doi: 10.1007/s10585-012-9505-1 GerliniG SestiniS Di GennaroP UrsoC PimpinelliN BorgognoniL Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy Clin Exp Metastasis 2013 30 37 45 10.1007/s10585-012-9505-1 Open DOISearch in Google Scholar

87. Cemazar M, Ambrozic Avgustin J, Pavlin D, Sersa G, Poli A, Krhac Levacic A, et al. Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours. Vet Comp Oncol 2017; 15: 641–54. doi: 10.1111/vco.12208 CemazarM Ambrozic AvgustinJ PavlinD SersaG PoliA Krhac LevacicA Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours Vet Comp Oncol 2017 15 641 54 10.1111/vco.12208 Open DOISearch in Google Scholar

88. Reed SD, Fulmer A, Buckholz J, Zhang B, Cutrera J, Shiomitsu K, et al. Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs. Cancer Gene Ther 2010; 17: 457–64. doi: 10.1038/cgt.2010.6 ReedSD FulmerA BuckholzJ ZhangB CutreraJ ShiomitsuK Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs Cancer Gene Ther 2010 17 457 64 10.1038/cgt.2010.6 Open DOISearch in Google Scholar

89. Tratar UL, Milevoj N, Cemazar M, Znidar K, Valentinuzzi KU, Brozic A, et al. Treatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: comparison of intratumoral and peritumoral application of IL-12. Int Immunopharmacol 2023; 120: 110274. doi: 10.1016/j.intimp.2023.110274 TratarUL MilevojN CemazarM ZnidarK ValentinuzziKU BrozicA Treatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: comparison of intratumoral and peritumoral application of IL-12 Int Immunopharmacol 2023 120 110274 10.1016/j.intimp.2023.110274 Open DOISearch in Google Scholar

90. Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26: 5896. doi: 10.1200/JCO.2007.15.6794 DaudAI DeContiRC AndrewsS UrbasP RikerAI SondakVK Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma J Clin Oncol 2008 26 5896 10.1200/JCO.2007.15.6794 Open DOISearch in Google Scholar

91. Sachdev S, Potočnik T, Rems L, Miklavčič D. Revisiting the role of pulsed electric fields in overcoming the barriers to in vivo gene electrotransfer. Bioelectrochemistry 2022; 144: 107994. doi: 10.1016/j.bioelechem.2021.107994 SachdevS PotočnikT RemsL MiklavčičD Revisiting the role of pulsed electric fields in overcoming the barriers to in vivo gene electrotransfer Bioelectrochemistry 2022 144 107994 10.1016/j.bioelechem.2021.107994 Open DOISearch in Google Scholar

92. Bulysheva A, Heller L, Francis M, Varghese F, Boye C, Heller R. Monopolar gene electrotransfer enhances plasmid DNA delivery to skin. Bioelectrochemistry 2021; 140: 107814. doi: 10.1016/j.bioelechem.2021.107814 BulyshevaA HellerL FrancisM VargheseF BoyeC HellerR Monopolar gene electrotransfer enhances plasmid DNA delivery to skin Bioelectrochemistry 2021 140 107814 10.1016/j.bioelechem.2021.107814 Open DOISearch in Google Scholar

93. Smith TR, Patel A, Ramos S, Elwood D, Zhu X, Yan J, et al. Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun 2020; 11: 2601. doi: 10.1038/s41467-020-16505-0 SmithTR PatelA RamosS ElwoodD ZhuX YanJ Immunogenicity of a DNA vaccine candidate for COVID-19 Nat Commun 2020 11 2601 10.1038/s41467-020-16505-0 Open DOISearch in Google Scholar

94. Potočnik T, Maček Lebar A, Kos Š, Reberšek M, Pirc E, Serša G, et al. Effect of Experimental electrical and biological parameters on gene transfer by electroporation: a systematic review and meta-analysis. Pharmaceutics 2022; 14: 2700. doi: 10.3390/pharmaceutics14122700 PotočnikT Maček LebarA KosŠ ReberšekM PircE SeršaG Effect of Experimental electrical and biological parameters on gene transfer by electroporation: a systematic review and meta-analysis Pharmaceutics 2022 14 2700 10.3390/pharmaceutics14122700 Open DOISearch in Google Scholar

95. Geboers B, Scheffer HJ, Graybill PM, Ruarus AH, Nieuwenhuizen S, Puijk RS, et al. High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy. Radiology 2020; 295: 254–72. doi: 10.1148/radiol.2020192190 GeboersB SchefferHJ GraybillPM RuarusAH NieuwenhuizenS PuijkRS High-voltage electrical pulses in oncology: irreversible electroporation, electrochemotherapy, gene electrotransfer, electrofusion, and electroimmunotherapy Radiology 2020 295 254 72 10.1148/radiol.2020192190 Open DOISearch in Google Scholar

96. Cindric H, Mariappan P, Beyer L, Wiggermann P, Moche M, Miklavcic D, et al. Retrospective study for validation and improvement of numerical treatment planning of irreversible electroporation ablation for treatment of liver tumors. IEEE Trans Biomed Eng 2021; 68: 3513–24. doi: 10.1109/TBME.2021.3075772 CindricH MariappanP BeyerL WiggermannP MocheM MiklavcicD Retrospective study for validation and improvement of numerical treatment planning of irreversible electroporation ablation for treatment of liver tumors IEEE Trans Biomed Eng 2021 68 3513 24 10.1109/TBME.2021.3075772 Open DOISearch in Google Scholar

97. Scuderi M, Dermol-Černe J, da Silva CA, Muralidharan A, Boukany PE, Rems L. Models of electroporation and the associated transmembrane molecular transport should be revisited. Bioelectrochemistry 2022; 147: 108216. doi: 10.1016/j.bioelechem.2022.108216 ScuderiM Dermol-ČerneJ da SilvaCA MuralidharanA BoukanyPE RemsL Models of electroporation and the associated transmembrane molecular transport should be revisited Bioelectrochemistry 2022 147 108216 10.1016/j.bioelechem.2022.108216 Open DOISearch in Google Scholar

98. Frandsen SK, Gehl J. A review on differences in effects on normal and malignant cells and tissues to electroporation-based therapies: a focus on calcium electroporation. Technol Cancer Res Treat 2018; 17: 1533033818788077. doi: 10.1177/1533033818788077 FrandsenSK GehlJ A review on differences in effects on normal and malignant cells and tissues to electroporation-based therapies: a focus on calcium electroporation Technol Cancer Res Treat 2018 17 1533033818788077 10.1177/1533033818788077 Open DOISearch in Google Scholar

99. Polajžer T, Miklavčič D. Immunogenic cell death in electroporation-based therapies depends on pulse waveform characteristics. Vaccines 2023; 11: 1036. doi: 10.3390/vaccines11061036 PolajžerT MiklavčičD Immunogenic cell death in electroporation-based therapies depends on pulse waveform characteristics Vaccines 2023 11 1036 10.3390/vaccines11061036 Open DOISearch in Google Scholar